Citadel Advisors LLC 13D and 13G filings for Bolt Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:19 pm Sale |
2024-09-30 | 13G | Bolt Biotherapeutics, Inc. BOLT |
Citadel Advisors LLC | 0 0.000% |
-2,458,958 (Position Closed) |
Filing |
| 2024-02-14 4:57 pm Sale |
2023-12-31 | 13G | Bolt Biotherapeutics, Inc. BOLT |
Citadel Advisors LLC | 2,458,958 6.500% |
-293,237 (-10.65%) |
Filing |
| 2023-02-14 08:02 am Sale |
2022-12-31 | 13G | Bolt Biotherapeutics, Inc. BOLT |
Citadel Advisors LLC | 2,752,195 7.300% |
-60,254 (-2.14%) |
Filing |
| 2022-02-14 06:12 am Sale |
2021-12-31 | 13G | Bolt Biotherapeutics, Inc. BOLT |
Citadel Advisors LLC | 2,812,449 7.500% |
-129,558 (-4.40%) |
Filing |
| 2021-02-19 4:03 pm Purchase |
2021-02-09 | 13G | Bolt Biotherapeutics, Inc. BOLT |
Citadel Advisors LLC | 2,942,007 8.100% |
2,942,007 (New Position) |
Filing |